Atlas Trials

Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis

Clinical trial NCT04461587 · COMPLETED

Trial details

NCT number
NCT04461587
Sponsor
Pulmonary Research of Abingdon, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Coal Workers' Pneumoconiosis (Complicated)
Start date
2020-08-31
Primary completion
2022-11-10
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.